BioSante Pharmaceuticals | Evaluate

October 05, 2012

Carcass of BioSante provides a nice shell for Ani

August 01, 2012

Therapeutic focus – Gleevec generic set to change the leukaemia landscape

December 15, 2011

LibiGel trial failure leaves BioSante investors unsatisfied

August 26, 2011

Event – LibiGel data could increase desire for BioSante

August 25, 2011

Most valuable unpartnered pipeline assets – what's hot and what's not

August 19, 2010

Therapeutic focus - What is plan B if A-beta Alzheimer's hypothesis is void?

December 22, 2009

Therapeutic focus - Gene therapy looking for a new hero

June 30, 2009

BioSante appears to see something in Cell Genesys beyond its cash